Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Chem., 09 October 2025

Sec. Medicinal and Pharmaceutical Chemistry

Volume 13 - 2025 | https://doi.org/10.3389/fchem.2025.1706525

Correction: Membrane-targeting antibacterial isoniazid schiff base against S. aureus and biofilms

This article is a correction to:

  1. Membrane-targeting antibacterial isoniazid schiff base against S. aureus and biofilms

    1. Read original article
Yaguang Liu Yaguang Liu*Lianzhi HuLianzhi HuBinbin LiuBinbin LiuZheng QuZheng Qu
  • Pharmacy Department, The Second Hospital of Qinhuangdao, Qinhuangdao, China

A Correction on
Membrane-targeting antibacterial isoniazid schiff base against S. aureus and biofilms

by Liu Y, Hu L, Liu B and Qu Z (2025). Front. Chem. 13:1654358. doi: 10.3389/fchem.2025.1654358

There was a mistake in Figure 7 as published. Panels A and B inadvertently contained duplicate images. The corrected Figure 7 appears below.

Figure 7
Bar graphs labeled A and B show the effects of different concentrations of C5 with LPS on NO concentration and TNF-alpha levels, respectively. Both graphs compare model and control groups with treatments at 16, 64, and 256 micrograms per milliliter. Significant reductions are indicated by asterisks and hashtags, with the highest concentrations showing the most reduction compared to the control.

Figure 7. Anti-inflammatory activity of the C5 compounds in RAW 264.7 macrophage cells was evaluated in the LPS-enhanced leukocyte migration assay. (A) C5 affects the level of NO. (B) C5 affects the level of TNF-α. Compared with the LPS model group, *p < 0.05, **p < 0.01, ***p < 0.001; ###p < 0.001 vs. control group. Data are presented as means ± SEM from three independent experiments.

The original article has been updated.

Generative AI statement

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: isoniazid, schiff base, antibacterial activity, anti biofilm, anti inflammatory

Citation: Liu Y, Hu L, Liu B and Qu Z (2025) Correction: Membrane-targeting antibacterial isoniazid schiff base against S. aureus and biofilms. Front. Chem. 13:1706525. doi: 10.3389/fchem.2025.1706525

Received: 16 September 2025; Accepted: 30 September 2025;
Published: 09 October 2025.

Edited and Reviewed by:

Marco Paolino, University of Siena, Italy

Copyright © 2025 Liu, Hu, Liu and Qu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yaguang Liu, aDQxODU2MTc1NEAxNjMuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.